I work in a comprehensive cancer center. My part is the Radiation and the other side is the Chemotherapy. The medical oncologists along with our radiation physicians discuss various ongoing trials often. I have heard the medical oncologists mention trials with neuvax, and they speak positive of this novel vaccine. Many drugs reach phase three only to fall short, fail, or sent back for more in depth testing etc etc. Nuevax, from what they expect will emerge positive. Nuevax, will become as common place #$%$ #$%$. They are excited about this one, and are awaiting data. this will be the new blue print and standard of care for many breast cancer patients. and a stepping stone to manage other type of cancers in the #$%$ture. Not Cure, but Manage effectively. keeping it in remission and at bay forever. Shareholders will be rewarded and for Cancer patients it will be priceless ! Just have patience.
very likely pps will continue a slow steady climb. more mm's and institutional players are now getting wind of the potential. They were waiting for this sign that everything is going as planned. The interim results will be positive and gale will be the monster of all biotechs soon. $2 is not unlikely within the next two weeks. positive results, we will be in double digits this year. then off to the races!
I believe news is coming next week about interim study, maybe even Monday. The news should be very positive in my opinion. I hope for the sake of the unfortunate cancer victims who may be able to benefit from neuvax, the news comes sooner than later. I work with some oncologists who said that neuvax may be the new standard of care as well as the new go to drug that will work well with Herceptin and possibly in conjunction with others. its an exciting time, and yes. there is some substance to the fact that their new guy worked for Jazz in the past. Gale has really cleaned up and tied loose ends. Im telling you something, Something is brewing! I wouldn't be surprised if the pps will be $3 plus by April